IL10 and pneumococcal pneumonia: Therefore, the present finding indicated that in the presence of concurrent treatment with AMP + AZM may lead to elevated circulating IL-10 that might influence bacterial outgrowth, suggesting that only in the latter phases of pneumococcal pneumonia is IL-10 essential for host defense.